[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@LmarieAsad](/creator/twitter/LmarieAsad) "How SpringWorks Took Pfizers Rare Disease Ghost Drug and Got It to Patients" [X Link](https://x.com/LmarieAsad/status/1981277580016689466) [@LmarieAsad](/creator/x/LmarieAsad) 2025-10-23T08:32Z 3012 followers, X engagements "French pharmaceutical company @sanofi drug known as #efdoralprin alfa met all of its main and key secondary goals in a Phase X study in people with #alpha1 antitrypsin deficiency or AATD. #liverhealth #RareDisease via @BioPharmaDive" [X Link](https://x.com/LmarieAsad/status/1981298142705332451) [@LmarieAsad](/creator/x/LmarieAsad) 2025-10-23T09:54Z 3009 followers, XX engagements "@GileadSciences #TLM2025" [X Link](https://x.com/LmarieAsad/status/1981411720414581127) [@LmarieAsad](/creator/x/LmarieAsad) 2025-10-23T17:25Z 3010 followers, X engagements "Great news @GileadSciences announced that Health Canada has approved #LYVDELZI (seladelpar) for the treatment of primary biliary cholangitis (#PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have had an inadequate response to UDCA alone. #liverhealth" [X Link](https://x.com/LmarieAsad/status/1981413614016737744) [@LmarieAsad](/creator/x/LmarieAsad) 2025-10-23T17:33Z 3009 followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@LmarieAsad
"How SpringWorks Took Pfizers Rare Disease Ghost Drug and Got It to Patients"
X Link @LmarieAsad 2025-10-23T08:32Z 3012 followers, X engagements
"French pharmaceutical company @sanofi drug known as #efdoralprin alfa met all of its main and key secondary goals in a Phase X study in people with #alpha1 antitrypsin deficiency or AATD. #liverhealth #RareDisease via @BioPharmaDive"
X Link @LmarieAsad 2025-10-23T09:54Z 3009 followers, XX engagements
"@GileadSciences #TLM2025"
X Link @LmarieAsad 2025-10-23T17:25Z 3010 followers, X engagements
"Great news @GileadSciences announced that Health Canada has approved #LYVDELZI (seladelpar) for the treatment of primary biliary cholangitis (#PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have had an inadequate response to UDCA alone. #liverhealth"
X Link @LmarieAsad 2025-10-23T17:33Z 3009 followers, XX engagements
/creator/twitter::3823922669/posts